Related Experiment Video
Updated: Jun 20, 2026

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
[Pneumocystis jiroveci pneumonia in an immunocompetent female patient]
1Service d'anesthésie réanimation, CHU Mohammed VI, 40000 Marrakech, Maroc. nejmihicham@yahoo.fr
Abstract:
Pneumocystis jirovecci is an opportunist fungal agent that usually causes pneumonia in immunocompromised patients, particularly those presenting with AIDS. In rare cases, this fungus can cause pneumonia in immunocompetent patients. The symptomatology in this case is acute and fulminant. We report the case of a Pneumocystis jirovecci pneumonia in a young patient initially admitted for acute respiratory distress. This case is unusual since all the exams performed to screen for immune deficit were negative. The diagnosis was made after identifying Pneumocystis jirovecci cysts in broncho-alveolar lavage.
Insights
Pneumocystis jirovecci pneumonia can occur in immunocompetent individuals, presenting acutely. Diagnosis in this case was confirmed via broncho-alveolar lavage, highlighting a rare clinical presentation.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Immunology
Background:
- Pneumocystis jirovecci is an opportunistic fungal pathogen.
- It typically causes severe pneumonia in immunocompromised individuals, especially those with Acquired Immunodeficiency Syndrome (AIDS).
- Rare instances of Pneumocystis pneumonia (PCP) in immunocompetent hosts are documented but remain unusual.
Observation:
- A young patient presented with acute respiratory distress syndrome.
- Extensive screening for immune deficiencies yielded negative results.
- The clinical presentation was acute and fulminant.
Findings:
- Pneumocystis jirovecci pneumonia was diagnosed in an immunocompetent young adult.
- Identification of Pneumocystis jirovecci cysts in broncho-alveolar lavage (BAL) confirmed the diagnosis.
- This case highlights PCP in a patient without identifiable immune deficits.
Implications:
- This case underscores the importance of considering PCP in immunocompetent patients with unexplained severe pneumonia.
- Early diagnosis through methods like broncho-alveolar lavage is crucial for timely intervention.
- Further research may elucidate the specific mechanisms enabling PCP in immunocompetent individuals.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
